← Eichor
Study identifier: NCT07449728 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Influence of Laser Crossectomy With Different Wavelengths on Varicose Vein Progression

Condition: Varicose Veins · Chronic Venous Insufficiency  ·  Sponsor: Pirogov Russian National Research Medical University

PhaseNA
Planned participants400
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Technically successful laser crossectomy will reduce the risk of reflux recurrence at the sapheno-femoral junction without increasing the risk of endovenous heat-induced thrombosis, which may positively impact the likelihood of ultrasound- or clinical-recurrence of varicose veins. Similar technical efficacy is expected for laser crossectomy at 1940 nm and 1470 nm. A possible advantage of the 1940 nm wavelength in terms of postoperative pain intensity and the risk of adverse events cannot be ruled out.

This description comes directly from the study's public registry record.

Talk to the study team

Kirill Lobastov, PhD  ·  +79852116331  ·  lobastov_kv@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

MedSwiss Private CinicMoscow, RussiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07449728